Search

For PHAVES #24 next week, veterinarian Dr. Whitney Greene & phage researcher Prof. Julianne Grose will give a talk entitled 'Phage Researcher & Veterinarian Perspective: Phage therapy to combat a shell infection in a sea turtle' on November

Conventional homology-based comparative genomic analyses can only do so much in extracting information from databases. We used phages to test our comparative genomics tool (CALANGO) that considers annotation terms besides sequence data. By

Check out the phage community question on Twitter by Dr. Sabrina Green (@MotherOfPhage). "This is a long shot maybe but does anyone have any Pseudomonas #phages that use the type IV pilus as a receptor? This is not for me but a collaborator

Head to YouTube and check out Bacteriophage in Arabic, a channel with a series of seminars and explanation videos about phage!

TechnoPhage announces first clinical safety results with their phage cocktail, TP-102, now advancing to phase 2. TP-102 is assessed for its safety and tolerability in individuals with diabetic foot ulcers, and showed no adverse effects in t

Adaptive Phage Therapeutics announced a strategic agreement with the Antibacterial Resistance Leadership Group to support a phase 1b/2 cystic fibrosis (CF) study. The randomized, double-blind, placebo-controlled trial will assess the safety

Victoria Turzynski (University of Duisburg-Essen, Germany) and colleagues published a new paper in Viruses showing imaging techniques for detecting prokaryotic viruses in environmental samples.

Rubén González (University of Valencia, Spain) and colleagues published a new paper in mBio showing the interplay between the host microbiome and pathogenic viral infections.

WIsH predicts the hosts of phages from their genomic sequences. It achieves 63% mean accuracy when predicting the host genus among 20 genera for 3 kbp-long phage contigs. WisH is also fast and accurate on phage sequences of a few kbp, makin

This week, McMaster University PhD student Kyle Jackson interviews Cytophage and BiomX executives, who share phage therapy commercialization challenges and progress and a sneak peek into what they'll present at Phage Futures. You can also

Phage Futures EU 2021 returns in-person in Brussels, Belgium on November 23-24! The theme will be 'Translating phage-based applications into clinically and commercially viable therapeutics'. Use code PHAGEDIRECTORY10 (or PD10) for a 10% di

What an INCREDIBLE turnout on Twitter for #WorldPhageWeek this week! Thanks so much to all who have participated in our daily prompts — we've learned so much about the phage community, how people got into phages, what their favourite phage

David Picton (Durham University, UK) and colleagues published a new paper in Nucleic Acids Research showing the phage defence island of a multidrug resistant plasmid uses both BREX and type IV restriction for complementary protection from v

We now know megaphages (phages with extremely large genomes) are ubiquitous, but before now, no complete marine megaphage had been identified. Slawomir Michniewski (University of Warwick) and colleagues published a new paper in ISME Communi

Carlos Martinez-Soto (Guelph Research and Development Centre, Canada) and colleagues published a new paper in Viruses describing PHIDA: a high throughput turbidimetric data analytic tool to compare host range profiles of phages isolated usi

Dipesh Khanal (University of Sydney, Australia) and colleagues published a new paper in International Journal of Pharmaceutics on enteric-coated phage tablets for oral administration against gastrointestinal infections.

The EMBO podcast has released a new episode entitled 'the enemy of my enemy: the return of phage therapy'. This episode interviews Jonathan Iredell and Ameneh Khatami about their recent publication in EMBO Molecular Medicine on the seven-ye

The University of California, Los Angeles is hiring a Tenure Track Assistant or Associate Professor in Quantitative Virology. The ideal candidate will lead a creative and impactful research program in quantitative virology and/or pathogen-i

The Raymond Lab at the University of Exeter, Cornwall (Penryn Campus) is seeking a PhD student to explore how to efficiently replace resistant Escherichia coli in the gut with harmless commensals by exploiting selective phage therapy.

The Weitz Lab at Georgia Institute of Technology, Atlanta is seeking PhD students to work on phage-microbe dynamics or epidemic dynamics. The Weitz Lab are also hiring two post-doctoral researchers to investigate viral life evolution or the